Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 3/Signature 2

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Svetlana up on 2025-1-4

Curated date: 2024/11/08

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Additional file 4: Figure S4

Description: Differentially abundant bacterial taxa between the naive and TB + HRZ groups at 2months into anti-tuberculosis HR(H-Isoniazid, R-Rifampin) therapy.

Abundance in Group 1: decreased abundance in TB +HRZ group - 2months into HR therapy(W12)

NCBI	Quality Control	Links
Acetanaerobacterium
Acetivibrio
Acidaminobacter
Alkaliphilus
Anaerovorax
Arthrobacter
Asaccharobacter
Bacteroides
Butyricicoccus
Caloramator
Christensenella
Clostridium
Coprobacter
Dorea
Dysgonomonas
Erysipelotrichaceae
Ethanoligenens
Gordonibacter
Hespellia
Odoribacter
Pediococcus
Peptococcus
Pseudobutyrivibrio
Robinsoniella
Romboutsia
Ruminococcus
Sporobacter
Stomatobaculum
Syntrophococcus
Turicibacter
Tyzzerella
Roseburia

Revision editor(s): KateRasheed